Hsbc Holdings PLC Purchases New Stake in Pediatrix Medical Group, Inc. $MD

Hsbc Holdings PLC purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 73,605 shares of the company’s stock, valued at approximately $1,854,000.

A number of other large investors have also added to or reduced their stakes in the company. Burney Co. bought a new position in Pediatrix Medical Group during the 1st quarter valued at approximately $1,129,000. Jennison Associates LLC purchased a new stake in Pediatrix Medical Group in the 4th quarter worth approximately $768,000. Renaissance Technologies LLC grew its position in shares of Pediatrix Medical Group by 12.9% in the 1st quarter. Renaissance Technologies LLC now owns 1,532,300 shares of the company’s stock worth $32,776,000 after buying an additional 174,600 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH grew its position in shares of Pediatrix Medical Group by 139.1% in the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 69,069 shares of the company’s stock worth $1,493,000 after buying an additional 40,176 shares during the last quarter. Finally, Fifth Third Bancorp increased its stake in shares of Pediatrix Medical Group by 7,643.2% during the first quarter. Fifth Third Bancorp now owns 62,333 shares of the company’s stock valued at $1,333,000 after buying an additional 61,528 shares during the period. Institutional investors own 97.71% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on MD. UBS Group raised their price target on Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Mizuho set a $24.00 price objective on shares of Pediatrix Medical Group in a research report on Friday, May 8th. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and upped their price objective for the stock from $27.00 to $28.00 in a report on Wednesday, August 19th. Truist Financial raised their target price on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Finally, Weiss Ratings lowered shares of Pediatrix Medical Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 25th. Seven equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and an average target price of $25.00.

Pediatrix Medical Group Stock Up 0.2%

NYSE:MD opened at $26.66 on Monday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.32 and a quick ratio of 1.32. The firm’s 50-day moving average price is $26.06 and its 200-day moving average price is $23.19. The company has a market capitalization of $2.17 billion, a PE ratio of 12.76 and a beta of 0.66. Pediatrix Medical Group, Inc. has a 1-year low of $15.69 and a 1-year high of $27.94.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.59 by $0.04. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The business had revenue of $487.78 million for the quarter, compared to analyst estimates of $478.49 million. During the same quarter in the previous year, the firm posted $0.53 earnings per share. Pediatrix Medical Group’s quarterly revenue was up 4.1% on a year-over-year basis. On average, equities analysts predict that Pediatrix Medical Group, Inc. will post 2.17 EPS for the current fiscal year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.